{
    "code": "02025968",
    "time": "2015-06-25 19:07:08",
    "許可證字號": "衛署藥輸字第025968號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/04\/08",
    "發證日期": "102\/04\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202596809",
    "中文品名": "艾泌平\"艾威群\"注射劑2毫克\/毫升",
    "英文品名": "Epirubicin \"Alvogen\" 2mg\/ml Injection solution",
    "適應症": "乳腺癌、惡性淋巴瘤、軟組織肉瘤、胃癌、肺癌、卵巢瘤。",
    "劑型": "270注射劑",
    "包裝": "5毫升、25毫升玻璃小瓶裝 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "EPIRUBICIN HCL",
    "限制項目": [
        "02輸入",
        "24監視期滿學名藥"
    ],
    "申請商名稱": "6401100487  台灣艾威群股份有限公司",
    "申請商地址": "台北市大安區信義路三段149號15樓",
    "主製造廠": {
        "製造廠名稱": "F160039000  GENEPHARM S.A.",
        "製造廠廠址": "18th km, Marathon Ave. - 15351 Pallini, Greece.",
        "製造廠公司地址": "",
        "製造廠國別": "GREECE",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012000910",
            "成分名稱": "EPIRUBICIN HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020259680001-2014-06-19.pdf 020259680006.pdf-102-05-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025968&Seq=002&Type=9"
        },
        {
            "title": "外盒 020259680002-2014-06-19.pdf 020259680004.pdf-102-05-08.pdf 020259680005.pdf-102-05-08.pdf 020259680003.pdf-102-05-08.pdf 020259680002.pdf-102-05-08.pdf 020259680001.pdf-102-05-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025968&Seq=006&Type=8"
        }
    ]
}